Touchstone
Last syncNov 1, 2026, 6:55 PM ET

GRDN

Guardian Pharmacy Services, Inc. Consumer Staples Retail-Drug Stores and Proprietary Stores Russell 3000
$40.69Close $27.03 – $48.0052-week range Nov 5, 2026Next report · after the close

Highlights

Strengths

  • Tight base near its pivot pullbacks 17% → 9% → 8%; 3.7% below its $42.26 pivot
  • Volume drying up last 10 days 39% under the 50-day average

Cautions

  • Trend not confirmed 7 of 8 conditions · under the 50-day
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 15%
1wk up 3.2% price change
1mo down 0.2% price change
12-month return up 44% market up 11% · its own up 32%
F-score — — Not assessed
Altman Z″ 3.85 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B — price / book
Earnings yield — EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 18% year on year
EPS growth — latest quarter
Sales growth up 2% latest quarter · -0 pts
ROE up 27% return on equity
Free cash margin up 6% $86.8M FCF
D/E 0.00 long-term debt / equity
Net debt / EBITDA -0.7× net cash
Interest cover —EBIT / interest

Trade setup

ATR% 3.6% $1.44 a day · 2×ATR $37.80
RS 74 / 99 vs the universe
Trend 7 / 8 under the 50-day
Relative volume 0.6× vs 50-day average
Up/down volume 0.82 50 sessions
Implied move — no option chain · report Nov 5, 2026
Contractions 3 17% → 9% → 8%
Pivot $42.26 3.7% below
Volume dry-up 0.6× 10 vs 50 sessions
Trend template · 7 of 8
  • Price above the 50-day average: fails

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 6, 2026
Results reaction Aug 6, 2026+8% vs market2 sessions after results

Financials

2 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.4B +18% on FY2024
$0 $2B FY24 FY25 FY2024 · $1.2B FY2025 · $1.4B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $49.2M back to a profit
-$200M $0 $50M FY24 FY25 FY2024 · -$110.0M FY2025 · $49.2M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $86.8M +101% on FY2024
$0 $100M FY24 FY25 FY2024 · $43.2M FY2025 · $86.8M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 20%
  • Net 3%
  • Free cash 6%
-10% 0% 25% FY24 FY25 FY2024 · Gross 20% · Net -9% · Free cash 4% FY2025 · Gross 20% · Net 3% · Free cash 6%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $65.6M net cash
  • Cash
  • Long-term debt
$0 $100M FY24 FY25 FY2024 · Cash $4.7M · Long-term debt $0 FY2025 · Cash $65.6M · Long-term debt $0
  FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.2B $1.4B
Gross margin 20% 20%
Operating income -$62.9M $72.7M
Net income -$110.0M $49.2M
Net margin -9% 3%
Free cash flow $43.2M $86.8M
Free cash margin 4% 6%
Cash $4.7M $65.6M
Long-term debt $0 $0
Shareholders' equity $150.0M $217.9M

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Mar 11, 2026 Annual ↗ Dec 31, 2025 70d
Nov 10, 2025 Quarterly ↗ Sep 30, 2025 41d
Aug 11, 2025 Quarterly ↗ Jun 30, 2025 42d
May 12, 2025 Quarterly ↗ Mar 31, 2025 42d
Nov 12, 2024 Quarterly ↗ Sep 30, 2024 43d

Current reports

FiledDisclosed
Sep 10, 2026 Other events ↗
Aug 6, 2026 Results ↗
Jun 22, 2026 Director or officer change · Regulation FD ↗
May 28, 2026 Material agreement · New obligation ↗
May 7, 2026 Shareholder vote ↗
May 6, 2026 Results ↗
Mar 23, 2026 Material agreement · Other events ↗
Mar 11, 2026 Results ↗
Jan 13, 2026 Results · Regulation FD ↗
Nov 10, 2025 Results ↗
Oct 14, 2025 Other events ↗
Sep 18, 2025 Regulation FD ↗